In a nutshell This study compared rituximab (Rituxan) and CT-P10 treatments for patients with previously untreated advanced stage follicular lymphoma. The study concluded that CT-P10 is just as safe and effective as name-brand rituximab. Some background Follicular lymphoma (FL) is a type of non-Hodgkin lymphoma. It is commonly treated...
Read More
In a nutshell This study looked at how effective erythropoietin mouthwash was at preventing oral mucositis in cancer patients being treated with autologous stem cell transplantation. The study concluded that rinsing with erythropoietin mouthwash can prevent oral mucositis. Some background Oral mucositis (OM) is a complication associated with...
Read More
In a nutshell This study looked at the outcomes of different types of initial treatment for patients diagnosed with early stage mantle cell lymphoma. The study concluded that a reduced intensity treatment approach is worthwhile for patients with early stage mantle cell lymphoma. Some background Mantle cell lymphoma (MCL) is a type of non-Hodgkin...
Read More
In a nutshell This study compared the effectiveness of rituximab (Rituxen) treatment when given subcutaneously or intravenously for patients with diffuse large B-cell lymphoma. The study concluded that subcutaneous rituximab is just as effective as intravenous rituximab, and has higher patient satisfaction. Some background Diffuse large B-cell...
Read More
In a nutshell This study compared rituximab and GP2013 treatments in patients with previously untreated advanced stage follicular lymphoma. The study concluded that patients treated with GP2013 had similar outcomes to patients treated with rituximab. Some background Follicular lymphoma (FL) is a type of non-Hodgkin lymphoma. It is commonly...
Read MoreIn a nutshell This study examined the effectiveness of lenalidomide (Revlimid) plus rituximab (Rituxan) in previously untreated follicular lymphoma. The authors concluded that this was a safe and effective first-line treatment option. Some background The first treatment often used in follicular lymphoma is rituximab combined with chemotherapy....
Read More
In a nutshell This study compared two different treatment approaches for patients with high-risk diffuse large B-cell lymphoma. The authors concluded that increasing treatment intensity early significantly improves survival for patients with high risk diffuse large B-cell lymphoma. Some background Diffuse large B-cell lymphoma (DLBCL) is the...
Read More
In a nutshell This study looked at the risk of developing heart failure among survivors of non-Hodgkin lymphoma. The study concluded that survivors with preexisting cardiovascular conditions were more likely to experience heart failure than people in the general population. Some background Non-Hodgkin lymphoma (NHL) is often treated with...
Read More
In a nutshell This study looked at how anxiety and depression influence the quality of life of patients with diffuse large-B cell lymphoma. The study concluded that anxiety, depression, and unmet patient needs negatively impact the physical and emotional wellbeing of patients. Some background Diffuse large B-cell lymphoma (DLBCL) is a common type...
Read More
In a nutshell This study looked at how effective a blood test was at predicting future outcomes in patients with relapsed or difficult to treat diffuse large B-cell lymphoma. The study concluded that the lymphocyte-to-monocyte ratio blood test is very effective at predicting future outcomes for patients with relapsed or difficult to treat diffuse large...
Read More
In a nutshell This study looked at the use of lenalidomide (Revlimid) treatment for patients with relapsed mantle cell lymphoma. The authors concluded that lenalidomide is generally safe and effective for treating patients with advanced stage relapsed or difficult to treat mantle cell lymphoma. Some background Mantle cell lymphoma (MCL) is an...
Read More
In a nutshell This article reviewed the use of obinutuzumab for patients with follicular lymphoma who have failed rituximab treatment. The article concluded that obinutuzumab treatment is useful for follicular lymphoma patients who have not responded well to rituximab regimens. Some background Follicular lymphoma (FL) is a common type...
Read More
